[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@neetu_csharma](/creator/twitter/neetu_csharma)
"Dr Reddy's @drreddys pivots to new growth levers as gRevlimids high-margin run fades. Next bets: Semaglutide Abatacept and the Stugeron portfolio. Read @business_today"  
[X Link](https://x.com/neetu_csharma/status/1983211726435688561) [@neetu_csharma](/creator/x/neetu_csharma) 2025-10-28T16:38Z 1227 followers, XX engagements